|
Market Closed -
Euronext Paris
19:55:00 26/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.190 EUR | -0.45% |
|
+1.86% | -19.19% |
| 10-01 | Taconic Biosciences, Inc. And genOway Partner To Expand U.S. Access To Advanced Humanized Mouse Models | CI |
| 09-23 | GenOway teams up with Taconic Biosciences to accelerate in the United States |  |
| Market Cap | 20.19M 22.58M 18.68M 16.91M 31.66M 2.15B 32.18M 225M 88.92M 1.12B 84.75M 82.94M 3.56B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 26.91M 30.09M 24.9M 22.54M 42.19M 2.86B 42.88M 300M 119M 1.5B 113M 111M 4.74B | EV / Sales 2024 |
1.36x | EV / Sales 2025 | 1.22x |
| Free-Float |
59.02% | Yield 2024 * |
-
| Yield 2025 | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALGEN | Real-time | |
Deutsche Boerse AG
| JEH | Delayed | |
|
Boerse Muenchen
| JEH | Real-time | |
|
Börse Stuttgart
| JEH | Delayed |
| 1 day | -0.45% | ||
| 1 week | +1.86% | ||
| Current month | -6.41% | ||
| 1 month | -7.20% | ||
| 3 months | -11.69% | ||
| 6 months | -12.40% | ||
| Current year | -19.19% |
| 1 week | 2.07 |  | 2.22 |
| 1 month | 2.01 | | 2.42 |
| Current year | 2.01 | | 2.79 |
| 1 year | 2.01 | | 2.88 |
| 3 years | 2.01 | | 4.91 |
| 5 years | 2.01 | | 4.91 |
| 10 years | 1 | | 7.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Operating Officer | - | 01/03/1999 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 01/10/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/03/1999 | |
| Chairman | - | - | |
Laurent Fraisse
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/20/22 A | Buy | Chief Executive Officer | 12,500 | 0.1376% | ||
| 11/17/21 A | Sell | Chief Executive Officer | 5,000 | 0.0553% | ||
| 11/13/21 A | Sell | Founder | 1,147 | 0.0127% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.45% | +1.86% | -20.07% | -44.13% | 22.71M | |
| +0.88% | +1.18% | +40.64% | +74.91% | 64.69B | |
| -0.26% | +7.23% | +11.14% | +74.78% | 54.78B | |
| +0.47% | +5.10% | +8.22% | +101.52% | 53.49B | |
| -2.06% | +2.51% | +24.07% | +50.98% | 45.98B | |
| -1.79% | +0.49% | +19.32% | +122.77% | 42.94B | |
| -1.65% | +3.34% | +237.56% | +819.04% | 40.08B | |
| -2.26% | -2.06% | +15.38% | +45.14% | 33.52B | |
| +0.22% | -4.77% | +26.59% | +0.55% | 23.97B | |
| +12.10% | +18.47% | +55.14% | +45.58% | 23.67B | |
| Average | +0.52% | +2.23% | +41.80% | +129.11% | 38.31B | |
| Weighted average by Cap. | +0.12% | +2.59% | +45.92% | +149.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 25.84M 28.9M 23.91M 21.65M 40.52M 2.75B 41.18M 288M 114M 1.44B 108M 106M 4.55B | 26.03M 29.11M 24.08M 21.8M 40.81M 2.77B 41.48M 290M 115M 1.45B 109M 107M 4.59B |
| Net income | 1.83M 2.05M 1.69M 1.53M 2.87M 195M 2.92M 20.38M 8.06M 102M 7.68M 7.52M 323M | 928K 1.04M 858K 777K 1.45M 98.71M 1.48M 10.33M 4.09M 51.63M 3.89M 3.81M 163M |
| Net Debt | 623K 697K 576K 522K 977K 66.28M 993K 6.94M 2.74M 34.67M 2.61M 2.56M 110M | 6.72M 7.51M 6.22M 5.63M 10.53M 715M 10.71M 74.79M 29.59M 374M 28.2M 27.6M 1.18B |
Employees
163
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/10/26 | €2.190 | -0.45% | 869 |
| 23/10/26 | €2.200 | 0.00% | 5,963 |
| 22/10/26 | €2.200 | -0.90% | 659 |
| 21/10/26 | €2.220 | +0.91% | 1,057 |
| 20/10/26 | €2.200 | 0.00% | 492 |
- Stock Market
- Stocks
- ALGEN Stock
Select your edition
All financial news and data tailored to specific country editions
